- CentralReach has tapped funding financial institution William Blair to weigh a possible sale, BI has discovered.
- The corporate makes digital well being data software program for autism care.
- One particular person with information of the efforts stated CentralReach might search a valuation of over $1 billion.
Autism care software program maker CentralReach has been exploring a sale, Enterprise Insider has discovered.
CentralReach has tapped the funding financial institution William Blair to pursue a possible sale, in response to individuals with information of the efforts.
Based in 2012, CentralReach sells digital well being data software program to suppliers caring for autism and associated mental and developmental issues. The corporate additionally builds AI-powered instruments inside its platform to assist suppliers automate duties like reviewing scientific notes.
CentralReach and William Blair did not reply to requests for remark for this story.
Fort Lauderdale, Florida-based CentralReach has been publicly quiet about its financials to this point. It is backed by enterprise and personal fairness agency Perception Companions, which invested an undisclosed sum into CentralReach in 2018.
Two individuals with information of CentralReach’s efforts stated the corporate has soared as a market-leading maker of software program for autism care. A type of individuals stated CentralReach is doing about $75 million in earnings earlier than deductions like taxes and curiosity.
That particular person stated they anticipate CentralReach to hunt a valuation north of $1 billion, based mostly on present market requirements.
Quite a few healthcare corporations have been trying to promote themselves after a sluggish yr for firm mixtures in 2024.
Traders and bankers informed Enterprise Insider in February that healthcare corporations which might be worthwhile and may exhibit steady income shall be much more enticing to patrons, particularly non-public fairness patrons.
Medical apply tech maker ModMed introduced Monday that it bought a majority stake to PE agency Clearlake Capital from Warburg Pincus, which first invested in ModMed in 2017. The corporate did not disclose the phrases of the acquisition, however the Monetary Instances reported the day earlier than that the deal valued ModMed at $5.3 billion.
CentralReach has additionally made a number of acquisitions prior to now few years, most just lately shopping for Conduct Science Know-how, which constructed a platform for measuring and monitoring the efficacy of autism remedy, in September. In its 13-year historical past, CentralReach has made 14 acquisitions.
CentralReach stated in a September launch that its tech is utilized by greater than 175,000 healthcare professionals globally.
